These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Fatal disseminated Anncaliia algerae myositis mimicking polymyositis in an immunocompromised patient. Ziad F; Robertson T; Watts MR; Copeland J; Chiu G; Wang D; Stark D; Graham L; Turner C; Newbury R Neuromuscul Disord; 2021 Sep; 31(9):877-880. PubMed ID: 34391631 [TBL] [Abstract][Full Text] [Related]
25. A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis. van den Bemt BJ; Vos K; den Broeder AA; Blom M; Thurlings RM; Bartelds GM; Stapel SO; Barrera P; Tak PP; Nurmohamed MT; Wolbink GJ Ann Rheum Dis; 2009 Aug; 68(8):1368-9. PubMed ID: 19605744 [No Abstract] [Full Text] [Related]
26. Anncaliia algerae Microsporidial Myositis, New South Wales, Australia. Sutrave G; Maundrell A; Keighley C; Jennings Z; Brammah S; Wang MX; Pamphlett R; Webb CE; Stark D; Englert H; Gottlieb D; Bilmon I; Watts MR Emerg Infect Dis; 2018 Aug; 24(8):1528-1531. PubMed ID: 30014835 [TBL] [Abstract][Full Text] [Related]
28. Development of fatal tuberculosis in a patient with rheumatoid arthritis after three years of treatment with infliximab: comment on the article by Wolfe et al. Molenaar ET; Bultink IE; Dijkmans BA; Lems WF Arthritis Rheum; 2005 Apr; 52(4):1334-6. PubMed ID: 15818690 [No Abstract] [Full Text] [Related]
29. Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis. Hammoudeh M Rheumatology (Oxford); 2006 Mar; 45(3):357-9. PubMed ID: 16368727 [No Abstract] [Full Text] [Related]
31. [Experiences with infliximab in the treatment of active rheumatoid arthritis and spondyloarthropathy]. Dahlin J; Sørensen SF Ugeskr Laeger; 2003 Nov; 165(48):4646-9. PubMed ID: 14677464 [No Abstract] [Full Text] [Related]
32. Early changes in bone metabolism in rheumatoid arthritis patients treated with infliximab. Vis M; Wolbink GJ; Lodder MC; Kostense PJ; van de Stadt RJ; de Koning MH; Dijkmans BA; Lems WF Arthritis Rheum; 2003 Oct; 48(10):2996-7. PubMed ID: 14558111 [No Abstract] [Full Text] [Related]
34. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis. Chan CY; Browning JC; Larsen F; Hsu S Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594 [TBL] [Abstract][Full Text] [Related]
35. Long-term efficacy of infliximab in autoimmune sensorineural hearing loss associated with rheumatoid arthritis. Gazeau P; Saraux A; Devauchelle-Pensec V; Cornec D Rheumatology (Oxford); 2014 Sep; 53(9):1715-6. PubMed ID: 24625506 [No Abstract] [Full Text] [Related]
36. Do etanercept-naive patients with rheumatoid arthritis respond better to infliximab than patients for whom etanercept has failed? Yazici Y; Erkan D Ann Rheum Dis; 2004 May; 63(5):607-8; author reply 608. PubMed ID: 15082503 [No Abstract] [Full Text] [Related]
39. Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles. Ettefagh L; Nedorost S; Mirmirani P Arch Dermatol; 2004 Aug; 140(8):1012. PubMed ID: 15313825 [No Abstract] [Full Text] [Related]
40. Use of infliximab in a patient with rheumatoid arthritis and chronic hepatitis B. Doubrawa E; Ricca RA; Malucelli TO; Pizzol VI; Barros DH; Paiva ES Rev Bras Reumatol; 2012 Aug; 52(4):653-5. PubMed ID: 22885430 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]